Browse by Audience
Skip to content
Papers of the Week
Mental disorders are no predictors to determine the duration of cannabis-based treatment for chronic pain.
Abstract
Chronic pain (CP), a complex biopsychosocial disorder with a global prevalence of up to 33%, can be treated by following multidisciplinary approaches that may include cannabis-based medicine (CBM). However, because CBM continues to be a new treatment, questions remain regarding the ideal duration for CBM and its psychosocial determinants, including mental comorbidities.